(Q35150337)

6 August 2017

1 reference

title

The malaria vaccine development program in Papua New Guinea (English)

1 reference

6 August 2017

0 references

1 reference

1 reference

1

Blaise Genton

1 reference

6 August 2017

John C Reeder

4

0 references

Robin Fredric Anders

series ordinal

2

object named as

Robin F Anders

1 reference

6 August 2017

Michael P Alpers

3

1 reference

6 August 2017

publication date

1 June 2003

1 reference

6 August 2017

published in

Trends in Parasitology

1 reference

6 August 2017

volume

19

1 reference

6 August 2017

issue

6

1 reference

6 August 2017

page(s)

264-270

1 reference

The economic and social burden of malaria

6 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4922%2803%2900111-9

7 January 2021

Sequence of Plasmodium falciparum chromosomes 2, 10, 11 and 14

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4922%2803%2900111-9

7 January 2021

Progress and challenges for malaria vaccines

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4922%2803%2900111-9

7 January 2021

Malaria vaccines: from the laboratory to the field

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4922%2803%2900111-9

7 January 2021

https://api.crossref.org/works/10.1016%2FS1471-4922%2803%2900111-9

1 reference

7 January 2021

Prospective risk of morbidity in relation to malaria infection in an area of high endemicity of multiple species of Plasmodium

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4922%2803%2900111-9

7 January 2021

The epidemiology of malaria in a population surrounding Madang, Papua New Guinea.

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4922%2803%2900111-9

7 January 2021

The epidemiology of malaria in the Wosera area, East Sepik Province, Papua New Guinea, in preparation for vaccine trials. I. Malariometric indices and immunity.

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4922%2803%2900111-9

7 January 2021

Relationships between Plasmodium falciparum infection and morbidity in a highly endemic area

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4922%2803%2900111-9

7 January 2021

Malaria: how useful are clinical criteria for improving the diagnosis in a highly endemic area?

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4922%2803%2900111-9

7 January 2021

The epidemiology of malaria in the Wosera area, East Sepik Province, Papua New Guinea, in preparation for vaccine trials. II. Mortality and morbidity.

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4922%2803%2900111-9

7 January 2021

Humoral response to Plasmodium falciparum ring-infected erythrocyte surface antigen in a highly endemic area of Papua New Guinea

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4922%2803%2900111-9

7 January 2021

Acquired antibody levels to Plasmodium falciparum merozoite surface antigen 1 in residents of a highly endemic area of Papua New Guinea

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4922%2803%2900111-9

7 January 2021

Cellular immunity to merozoite surface protein 2 (FC27 and 3D7) in Papua New Guinean children. Temporal variation and relation to clinical and parasitological status

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4922%2803%2900111-9

7 January 2021

Assessment of the humoral and cell-mediated immunity against the Plasmodium falciparum vaccine candidates circumsporozoite protein and SPf66 in adults living in highly endemic malarious areas of Papua New Guinea.

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4922%2803%2900111-9

7 January 2021

Assessment of the role of naturally acquired antibody levels to Plasmodium falciparum merozoite surface protein-1 in protecting Papua New Guinean children from malaria morbidity

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4922%2803%2900111-9

7 January 2021

Assessment of the role of the humoral response to Plasmodium falciparum MSP2 compared to RESA and SPf66 in protecting Papua New Guinean children from clinical malaria

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4922%2803%2900111-9

7 January 2021

Association between cellular response (IL-4) to RESA/Pf155 and protection from clinical malaria among Papua New Guinean children living in a malaria endemic area

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4922%2803%2900111-9

7 January 2021

Plasmodium falciparum: extensive polymorphism in merozoite surface antigen 2 alleles in an area with endemic malaria in Papua New Guinea

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4922%2803%2900111-9

7 January 2021

Molecular monitoring in malaria vaccine trials

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4922%2803%2900111-9

7 January 2021

Spatial and temporal variation in abundance of Anopheles (Diptera:Culicidae) in a malaria endemic area in Papua New Guinea

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4922%2803%2900111-9

7 January 2021

Occurrence of the erythrocyte band 3 (AE1) gene deletion in relation to malaria endemicity in Papua New Guinea

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4922%2803%2900111-9

7 January 2021

Ovalocytosis and cerebral malaria

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4922%2803%2900111-9

7 January 2021

alpha+-Thalassemia protects children against disease caused by other infections as well as malaria

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4922%2803%2900111-9

7 January 2021

Assessment of different sources of variation in the antibody responses to specific malaria antigens in children in Papua New Guinea

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4922%2803%2900111-9

7 January 2021

Effect of vitamin A supplementation on morbidity due to Plasmodium falciparum in young children in Papua New Guinea: a randomised trial

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4922%2803%2900111-9

7 January 2021

The influence of zinc supplementation on morbidity due to Plasmodium falciparum: a randomized trial in preschool children in Papua New Guinea.

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4922%2803%2900111-9

7 January 2021

Human phase I vaccine trials of 3 recombinant asexual stage malaria antigens with Montanide ISA720 adjuvant

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4922%2803%2900111-9

7 January 2021

Safety and immunogenicity of a three-component blood-stage malaria vaccine in adults living in an endemic area of Papua New Guinea

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4922%2803%2900111-9

7 January 2021

A recombinant blood-stage malaria vaccine reduces Plasmodium falciparum density and exerts selective pressure on parasite populations in a phase 1-2b trial in Papua New Guinea

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4922%2803%2900111-9

7 January 2021

Plasmodium falciparum: malaria morbidity is associated with specific merozoite surface antigen 2 genotypes

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4922%2803%2900111-9

7 January 2021

Modeling malaria vaccines. II: Population effects of stage-specific malaria vaccines dependent on natural boosting

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4922%2803%2900111-9

7 January 2021

10.1016/S1471-4922(03)00111-9

Identifiers

DOI

1 reference

6 August 2017

1 reference